Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-27

Clinical Trial Update: Role of Dexamethasone in the Conservative Treatment of Chronic Subdural Hematoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluated dexamethasone for conservative treatment of chronic subdural hematoma. The study was terminated and results were posted in 2015…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Hematoma, Subdural, Chronic | Phase 4 | Status: TERMINATED | Results posted: 2015-02-27